Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ESRX

Express Scripts

$61.82

0.82 (1.34%)

, NVS

Novartis

$85.01

-0.77 (-0.90%)

14:41
09/21/17
09/21
14:41
09/21/17
14:41
Hot Stocks
Express Scripts CMO discusses 'great promise, big price' of gene therapy »

In a post to the…

ESRX

Express Scripts

$61.82

0.82 (1.34%)

NVS

Novartis

$85.01

-0.77 (-0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 22

    Sep

  • 25

    Oct

  • 08

    Nov

  • 17

    May

TEVA

Teva

$17.14

0.031 (0.18%)

10:20
09/21/17
09/21
10:20
09/21/17
10:20
Options
Defensive option play opened in TEVA »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

ALIOF

Actelion

$277.27

-2.73 (-0.98%)

09:45
09/21/17
09/21
09:45
09/21/17
09:45
Conference/Events
Actelion has a conference call hosted by JPMorgan »

JPMorgan Analyst Gordon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

AMD

AMD

$13.74

0.62 (4.73%)

, MRO

Marathon Oil

09:40
09/21/17
09/21
09:40
09/21/17
09:40
Options
Unusually active option classes on open September 21st »

Unusual total active…

AMD

AMD

$13.74

0.62 (4.73%)

MRO

Marathon Oil

NVDA

Nvidia

$185.84

-1.51 (-0.81%)

GLD

SPDR Gold Trust

JD

JD.com

$44.44

0.11 (0.25%)

SLV

iShares Silver Trust

TEVA

Teva

GDX

Market Vector Gold Miners

NUGT

Direxion Gold Miners Bull

KR

Kroger

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 10

    Oct

  • 11

    Oct

  • 02

    Nov

  • 30

    Nov

NBIX

Neurocrine

$56.80

0.47 (0.83%)

, TEVA

Teva

09:34
09/21/17
09/21
09:34
09/21/17
09:34
Recommendations
Neurocrine, Teva analyst commentary at Baird »

Baird physician survey…

NBIX

Neurocrine

$56.80

0.47 (0.83%)

TEVA

Teva

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

MDT

Medtronic

09:33
09/21/17
09/21
09:33
09/21/17
09:33
Hot Stocks
Medtronic announces new study to evaluate CoreValve Evolut PRO valve »

Medtronic announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LJPC

La Jolla

$34.58

1.58 (4.79%)

09:25
09/21/17
09/21
09:25
09/21/17
09:25
Conference/Events
JPMorgan SMid biotech analyst holds an analyst/industry conference call »

SMid Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 28

    Feb

REGN

Regeneron

$438.17

6.79 (1.57%)

, AMGN

Amgen

$188.17

1.85 (0.99%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Regeneron, Amgen, AstraZeneca, AbbVie analyst commentary at UBS »

Regeneron price target…

REGN

Regeneron

$438.17

6.79 (1.57%)

AMGN

Amgen

$188.17

1.85 (0.99%)

AZN

AstraZeneca

$32.93

0.26 (0.80%)

ABBV

AbbVie

$87.41

1.04 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

  • 27

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

NSPR

InspireMD

$0.32

0.0021 (0.65%)

07:32
09/21/17
09/21
07:32
09/21/17
07:32
Hot Stocks
InspireMD announces distribution agreement for CGuard EPS in Portugal »

InspireMD announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$82.64

0.35 (0.43%)

06:05
09/21/17
09/21
06:05
09/21/17
06:05
Hot Stocks
Gilead receives approval in Canada for expanded indication of Epclusa »

Gilead Sciences Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.